A narrative, hypothesis-driven review and guideline focuses on patients with postural orthostatic tachycardia syndrome (POTS). It proposes a physiological reframing that distinguishes compensatory orthostatic tachycardia in POTS from primary autonomic failure, as seen in neurogenic orthostatic hypotension. The core intervention is mechanistic phenotyping to identify dominant contributors within POTS, including low-preload/pooling, neuropathic, hyperadrenergic, immune-associated, and secondary structural or CSF-pressure factors. The guideline does not report specific study sample size, setting, or follow-up duration.
No quantitative main results, safety data, or tolerability information are reported. Adverse events, serious adverse events, and discontinuation rates are not described.
A key limitation noted is that the label 'dysautonomia' is frequently applied imprecisely in POTS and is often misinterpreted as autonomic failure. The authors caution that this reframing does not minimize the severity of POTS. Funding sources and conflicts of interest are not reported.
In practice, this conceptual framework supports clearer patient counseling and more targeted therapy by treating tachycardia as a signal of orthostatic stress and investigating its underlying drivers. The evidence is based on expert review and physiological reasoning rather than new clinical trial data.
View Original Abstract ↓
Postural orthostatic tachycardia syndrome (POTS) is defined by chronic orthostatic intolerance accompanied by an excessive increment in sinus heart rate on standing in the absence of significant orthostatic hypotension. Contemporary reviews and consensus statements appropriately frame POTS as involving autonomic regulation. Yet the bedside phenotype most often observed-marked tachycardia with preserved blood pressure-also supports a hemodynamic interpretation: an intact baroreflex driving tachycardia to defend cardiac output and cerebral perfusion when effective stroke volume or venous return is reduced. This narrative, hypothesis-driven review argues that the umbrella label ‘dysautonomia’ is frequently applied imprecisely in POTS and is often interpreted (by clinicians and patients) as autonomic failure. In many patients, the dominant physiology is not autonomic failure but compensatory activation in response to orthostatic stressors such as low central blood volume, venous pooling, impaired vasoconstriction, or deconditioning. When the label is over-interpreted, management can drift toward reflexive heart-rate suppression rather than mechanism-directed evaluation and treatment of the orthostatic stressor. We propose a pragmatic, cardiology-facing framework that (1) distinguishes compensatory orthostatic tachycardia from primary autonomic failure (neurogenic orthostatic hypotension), and (2) prioritizes mechanistic phenotyping within POTS (low-preload/pooling dominant, neuropathic, hyperadrenergic, immune-associated, and secondary structural/CSF-pressure contributors). This reframing does not minimize the severity of POTS; rather, it supports clearer counseling and more targeted therapy by treating tachycardia as a signal of orthostatic stress and asking what is driving it.